IgA vasculitis in patients with inflammatory bowel disease: new insights into the role of TNF-α blockers.

MLA

Rasmussen, Camille, et al. “IgA Vasculitis in Patients with Inflammatory Bowel Disease: New Insights into the Role of TNF-α Blockers.” Rheumatology, vol. 61, no. 5, May 2022, pp. 1957–65. EBSCOhost, https://doi.org/10.1093/rheumatology/keab662.

APA

Rasmussen, C., Abitbol, V., Karoui, K. E., Bourrier, A., Paule, R., Vuitton, L., Maurier, F., Laharie, D., Fuméry, M., Agard, C., Collins, M., Nancey, S., Rafat, C., Kervegant, A.-G., Queyrel-Moranne, V., Moulis, G., Pigneur, B., Régent, A., Gay, C., & Morbieu, C. (2022). IgA vasculitis in patients with inflammatory bowel disease: new insights into the role of TNF-α blockers. Rheumatology, 61(5), 1957–1965. https://doi.org/10.1093/rheumatology/keab662

Chicago

Rasmussen, Camille, Vered Abitbol, Khalil El Karoui, Anne Bourrier, Romain Paule, Lucine Vuitton, François Maurier, et al. 2022. “IgA Vasculitis in Patients with Inflammatory Bowel Disease: New Insights into the Role of TNF-α Blockers.” Rheumatology 61 (5): 1957–65. doi:10.1093/rheumatology/keab662.